Company intelligence / Profile preview

Endo Par Innovation Company

Rochester, Michigan, United States

Ownership: Private
Employees: ~2000
Development stage: Other

Overview

The combined Endo/Par business markets a large portfolio of branded and generic therapeutics and has been a leader in high-barrier-to-entry or first-to-market generics, sterile injectables, and specialty products; the business maintains a significant R&D and product development pipeline for generics and specialty indications

Therapeutic areas: CardiovascularNeurologyMen's HealthRheumatologyImmunologyEndocrinologyInfectious DiseasesOther
Modalities: Small moleculeSterile injectableGeneric drugsProteinVaccine
Industry: Biotech

Partnerships

Department of Defense (pandemic preparedness/fill-finish manufacturing)clinical trial site networksnumerous hospital and health system providers

Beyond the preview

Go deeper on Endo Par Innovation Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endo Par Innovation Company.

Explore the full profile